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“Not everything that can be counted counts, and not everything that counts can be counted.”  – 
Albert Einstein 
 
Data to support adenoma detection rate (ADR) as a measure of colonoscopy quality and cancer protection 
continue to emerge,1 along with evidence that behavior changes favorably when ADR is tracked.2 
However, ADR can be a challenging metric to obtain, given the disparity in systems for pairing 
colonoscopy and pathology reports. Although several surrogate measures have been suggested as 
appropriate for quantifying quality (eg, ADR, polypectomy rate), the potential for gaming the system 
makes them less attractive,3 implying that the easiest metrics to count may not be the most useful ones. 
What is needed are 1 or more robust quality measures and an automated, accurate method for obtaining 
them. The mean number of adenomas per screening colonoscopy has been proposed as less prone to 
gaming than the ADR, but no data have linked this measure to outcomes.4 
 
Natural language processing (NLP) is a method of searching within text documents that has been used for 
obtaining multiple quality measures in endoscopy, especially the ADR (Table 1). Since 2011, several 
institutions have developed customized in-house automated systems for quantifying ADR, advanced 
ADR, and site-specific ADR (proximal/distal), precluding the need for manual review. As providers of an 
effective but expensive and invasive technology, we endoscopists will soon be required to quantify 
colonoscopy quality for payers.5 Although the potential for a system that uses artificial intelligence to 
track our services is no longer considered far-fetched, this vision must be tempered with consideration of 
what and how a metric is to be measured. There is a pressing need for a simple, yet accurate, method for 
moving toward an optimal system of tracking colonoscopy quality. 
In this issue of Gastrointestinal Endoscopy, Raju and colleagues 6 report their experience with the 
computer application for ADR reporting (CAADRR). The CAADRR was developed to extract 
colonoscopy reports from existing endoscopy software and link them with associated pathology reports. 
These reports were then processed with text mining to determine colonoscopy indication (ie, screening) 
and the findings of adenomas and sessile serrated polyps (SSPs). The authors validated this system 
against a manually curated data set and showed accuracy rates of 91.3% for detecting screening 
examinations, 99.4% for adenomas, and 100% for SSPs. These high rates are consistent with previous 
reports of single-center accuracy with the use of NLP. 7, 8, 9 and 10 From text mining of the reports, Raju 
et al were able to measure individual endoscopist’s ADRs, which ranged from 22% to 62%, along with 
gender-stratified ADRs. 
 
The authors are to be congratulated for creating a carefully constructed and sensible tracking system for 
several quality metrics. Although this work further establishes the ability of computer techniques to 
obtain a validated measurement of colonoscopy quality, it is not without limitations (as are previous 
efforts to advance NLP-based quality measurement of colonoscopies).6, 7, 8, 9 and 10 First, there appears 
to have been no differentiation between a training set and a test set, which increases both the potential for 
overtraining and the chance of less accurate performance when the method is applied to subsequent 
patient cohorts. Second, because traditional NLP was not used, the CAADRR system is unable to use 
context-specific term identification. As a result, the phrase “no … adenoma” would potentially count as 
an adenoma by the CAADRR system, whereas it would be recognized as a negated term by a complex 
NLP system; the misspelled word “adnoma” would be potentially missed with CAADRR but identified 
by NLP. Third, the CAADRR system has no method for finding adenomas 10 mm or larger, omitting the 
inclusion of this large subgroup of advanced adenomas from specific identification. The number of 
adenomas per colonoscopy, which may be a better quality metric than ADR, is also not possible to 
quantify in the CAADRR system. Furthermore, the accuracy of identifying a “screening” colonoscopy 
may be questioned because patients with rectal bleeding and a positive fecal blood test result were 
counted as “screening,” whereas those with “family history of colorectal cancer” were excluded without 
specifically being first-degree relatives. Last, this is a single-center tool that was created on templated 
endoscopy software with a single pathology reporting system. Although the tool may work well on its 
“home court,” the methods used to create it may not apply as well to other systems. 
 
Despite advances made by several groups of investigators in automated measuring of selected quality 
determinations (Table 1), there are and will likely remain several other determinants of colonoscopy 
quality that are not reflected in procedure note documentation. These include adequacy of luminal 
distention and examining the proximal sides of flexures, folds, and valves—techniques associated with 
lower adenoma miss rates.11 Although video recording of colonoscopies and randomly reviewing 
withdrawal techniques is a possibility,12 the practicality of implementing these practices may be too 
costly and time-consuming. 
 
In 2015, technology pervades our professional life, with each clinical encounter systematically logged 
into the electronic medical record. The opportunity to use secondary data to improve the quality of health 
services and patient outcomes is apparent. However, we must temper our enthusiasm with reality. We 
must accept that not all patients for a provider or panels of patients among providers are the same. For 
example, a quality metric such as ADR must be coupled with adjustment for factors that affect risk for 
colorectal neoplasia (eg, age, gender, certain family histories, results of previous screening tests). An 
adjusted ADR would appropriately reduce unwanted variations caused by these factors, resulting in a 
better quality metric. Furthermore, today’s best quality metric may not be tomorrow’s. Mean adenoma 
number per screening colonoscopy may be a more robust, more “tamperproof” metric,13 so any 
technology used for quality monitoring must be adaptable to changing measures of quality. With the 
challenge of detecting SSPs, an SSP detection rate may be most indicative of high-quality colonoscopy, 
although variations in pathologic interpretation must be addressed definitively before further study.14 
 
The optimal system will allow an endoscopist to perform a colonoscopy, create a colonoscopy report in 
an electronic format (endoscopy software or dictation), associate that report to a subsequent pathology 
report, extract meaningful quality measures (eg, ADR, ADR per procedure, advanced ADR, proximal 
ADR), adjust these rates for important covariates, and report these to the provider, a quality monitoring 
system (eg, the GI Quality Improvement Consortium), and the payer, all without any human review. A 
seamless process using NLP would both allow full transparency of care and encourage practice 
improvement. We are not too far from such a system, but before we can count a quality measure, we 
should know and accept the optimal measure(s) to count. 
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Table 1. Summary of selected studies using natural language processing–based extraction of adenoma detection rate 
Study Objectives Methods Results ADR What the study 
adds 
Harkema 
et al 
(2011)7 
Develop NLP 
application to 
measure colonoscopy 
quality 
Newly created 
NLP engine tested 
against manual 
review of 453 
free-text 
colonoscopy and 
226 pathology 
reports for 
identifying data 
for 19 quality 
measures 
Accuracy of 89% 
(range<comma> 62%-
100%) for the 19 
quality measures 
Individual 
endoscopist ADRs 
range from 14.9% 
to 33.9% 
NLP can identify 
with reasonable 
accuracy data 
elements for 
quality 
assessment of 
colonoscopy 
Imler et 
al 
(2013)8 
Create and test NLP 
program to identify 
the most advanced 
level of pathologic 
lesions found on 
colonoscopy 
500 linked 
colonoscopy and 
pathology reports 
used to train and 
test an open-
source NLP 
engine against 
paired annotation 
of reports by 
blinded 
endoscopists 
NLP identified highest 
level of pathologic 
change with 98% 
accuracy. Accuracies 
for location<comma> 
size<comma> and 
number were 
97%<comma> 
96%<comma> and 
84%<comma> 
respectively 
Overall institutional 
ADR of 46.5% and 
advanced ADR of 
15.7% 
NLP can identify 
the most 
advanced level of 
pathologic lesion 
and its size and 
anatomic location 
Gawron 
et al 
(2014)9 
Use open-source 
NLP to assess 
total<comma> 
anatomic<comma> 
and advanced ADRs 
Performance of an 
open-source NLP 
engine was tested 
against manual 
validation of 200 
procedures with 
associated 
pathology reports 
NLP reported 
screening indication 
and completed 
procedure with 98% 
accuracy<comma> and 
correct pathologic 
lesion and location 
with 94% accuracy 
Overall ADR of 
20.3%<comma> 
left-sided ADR of 
10.1%<comma> 
right-sided ADR of 
12.5%<comma>and 
advanced ADR of 
4.4% 
Established 
ability to measure 
advanced and 
anatomic ADRs 
Imler 
(2015)10 
Determine feasibility 
and performance of 
NLP in 13 VA 
750 random 
colonoscopies 
from a sample of 
NLP identified highest 
pathologic lesion with 
94.6%-99.8% accuracy 
ADR per center 
ranged from 19.3% 
to 38%; advanced 
Demonstrates 
high accuracy for 
pathologic lesion 
centers for pathologic 
lesion and anatomic 
location 
>40<comma>000 
linked 
colonoscopy and 
pathology reports 
were used to train 
and test an open-
source NLP 
engine against 
paired annotation 
of reports by 
blinded 
endoscopists 
and location with 87%-
99.8% accuracy 
ADR was 7.7%; 
SSP detection rate 
was 0.6%; and 
proximal ADR was 
11.4% 
and location 
among multiple 
centers 
Raju et 
al 
(2015)6 
Develop NLP 
mechanism to 
identify screening 
colonoscopies and 
determine ADR 
Multiple manually 
curated reports 
compared against 
NLP extraction 
with single 
gastroenterology 
review and 
mismatches 
assessed by a 
separate 
gastroenterologist 
NLP identified 91.3% 
of screening 
examinations<comma> 
99.4% of reports for 
adenomas<comma> 
and 100% of reports 
for SSPs 
Overall ADR was 
43%<comma> with 
individual 
endoscopist’s 
ADRs ranging from 
22% to 62% 
NLP can 
accurately 
identify screening 
examinations and 
report individual 
endoscopist’s 
ADR 
 
